Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Dawnrays Pharmaceutical Holdings Ltd

+ Add to Watchlist

2348:HK

7.170 HKD 0.240 3.46%

As of 04:01:05 ET on 05/22/2015.

Snapshot for Dawnrays Pharmaceutical Holdings Ltd (2348)

Open: 6.930 Day's Range: 6.920 - 7.190 Volume: 1,272,000
Previous Close: 6.930 52wk Range: 3.910 - 8.130 1-Yr Rtn: +25.54%

Stock Chart for 2348

No chart data available.
  • 2348:HK 7.170
  • 1D
  • 1M
  • 1Y
6.930
Interactive 2348 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 2348

Current P/E Ratio (ttm) 22.4970
Estimated P/E(12/2015) 17.2139
Relative P/E vs. HSI 1.8963
Earnings Per Share (CNY) (ttm) 0.2548
Est. EPS (CNY) (12/2015) 0.3330
Est. PEG Ratio -
Market Cap (M HKD) 5,767.03
Shares Outstanding (M) 804.33
30 Day Average Volume 1,880,572
Price/Book (mrq) 3.7079
Price/Sale (ttm) 5.8939
Dividend Indicated Gross Yield 1.53%
Cash Dividend (HKD) 0.0850
Dividend Ex-Date 05/27/2015
5 Year Dividend Growth 6.46%
Next Earnings Announcement 08/21/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 2348

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 2348

Dawnrays Pharmaceutical (Holdings) Limited, through its subsidiaries, develops, manufactures, and sells non-patented chemical medicines including cephalosporins in sterile bulk medicine and powder for injection forms, their intermediate pharmaceuticals and system specific medicines. The Group produces a series of cephalosporins with various therapeutic uses.

Wu JihongVP/ControllerHung Yung LaiExecutive Director/Co-Founder
Li Tung MingExecutive DirectorPang Kit LingSecretary
More Company Profile & Key Executives for 2348

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil